Quest Diagnostics Incorporated DGX

Healthcare — Diagnostics & Research

236.32 (0.27) (0.11%) as of 25 Sep

Market cap: $26.2B
P/E: 24.8×

Follow DGX

S&P 500 Member Dividend Champion (5y)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
P/E ratio	19.56	19.39	18.55	19.33	10.90	11.24	16.79	15.45	17.57	20.23
P/S ratio	1.75	1.70	1.70	1.83	2.00	1.69	1.85	1.50	1.83	1.79
P/FCF ratio	14.17	18.42	18.25	13.75	11.82	10.06	16.97	13.86	14.68	15.73
P/Operating CF	41.42	36.09	29.93	54.10	44.96	29.52	41.12	38.39	41.95	36.87
P/B ratio	2.67	2.46	2.49	3.05	3.34	2.35	2.52	2.15	2.73	2.78
Price to Tangible BV	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EV/Sales	2.22	2.27	2.14	2.20	2.30	1.99	2.32	2.00	2.32	2.26
EV/EBITDA	11.53	12.19	11.64	11.65	8.88	8.07	11.47	10.70	11.98	10.69
EV/Operating CF	13.00	16.80	15.57	12.65	11.09	9.39	14.39	12.57	14.64	14.62
EV/FCF	18.04	24.66	22.92	16.54	13.53	11.86	21.22	18.46	18.63	19.83
Quick Ratio	0.80	0.85	1.04	0.97	1.32	1.51	1.13	0.77	1.00	1.31
Current Ratio	1.04	1.10	1.31	1.22	1.56	1.72	1.25	0.94	1.24	1.56
Net Debt/EBITDA	2.47	3.08	2.37	1.97	1.13	1.23	2.29	2.67	2.54	2.21
Debt/Assets	34.95%	38.49%	33.61%	31.00%	29.48%	28.63%	37.14%	35.38%	36.03%	36.97%
Debt/Equity	0.79	0.91	0.74	0.67	0.62	0.59	0.84	0.74	0.76	0.80
Asset Turnover	0.68	0.65	0.69	0.75	0.78	0.70	0.65	0.70	0.72	0.72
Operating CF/Net income	1.91	1.54	1.50	1.82	1.12	1.41	1.45	1.63	1.52	1.74
Capex/Depreciation	(0.92)	(0.86)	(0.93)	(0.92)	(0.99)	(1.16)	(1.22)	(1.24)	(0.93)	(1.18)
Interest Coverage	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE	14.10%	13.17%	13.85%	15.18%	29.91%	22.81%	15.67%	14.40%	16.06%	13.70%
ROA	6.10%	5.74%	6.33%	7.12%	14.39%	10.61%	7.20%	6.84%	7.49%	6.40%
ROIC	7.81%	6.74%	7.61%	9.30%	15.46%	12.74%	8.30%	7.62%	8.46%	9.93%
Return on Tangible Assets	42.90%	37.07%	35.82%	44.58%	73.77%	48.99%	43.93%	61.69%	55.38%	40.66%
Average Days of Receivables	46.57	48.21	47.74	44.13	48.65	58.79	50.22	49.05	45.56	46.85
Research and Development Expense of Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue	17.83%	17.93%	17.75%	18.96%	16.01%	16.42%	18.86%	18.91%	19.49%	19.13%
Intangible Assets out of Total Assets	0.65	0.66	0.63	0.65	0.61	0.57	0.60	0.71	0.71	0.69
Share Based Compensation of Revenue	0.80%	0.89%	0.83%	0.78%	0.73%	1.03%	0.72%	0.81%	1.07%	0.96%
Graham Net Nets	(0.34)	(0.41)	(0.34)	(0.28)	(0.20)	(0.26)	(0.33)	(0.38)	(0.31)	(0.30)
Graham Number	113.83	103.65	98.34	96.28	136.09	110.09	77.93	68.53	67.69	58.50
Earnings Yield	5.11%	5.16%	5.39%	5.17%	9.17%	8.89%	5.96%	6.47%	5.69%	4.94%
Free Cash Flow Yield	7.06%	5.43%	5.48%	7.27%	8.46%	9.94%	5.89%	7.21%	6.81%	6.36%
Revenue per Share	99.41	88.94	82.61	85.20	86.30	70.43	57.66	55.38	54.03	51.53
Operating CF per Share	16.99	12.02	11.36	14.81	17.86	14.96	9.28	8.82	8.58	7.97
Capex per Share	(4.75)	(3.83)	(3.64)	(3.48)	(3.22)	(3.12)	(2.99)	(2.82)	(1.84)	(2.09)
Free Cash Flow per Share	12.24	8.19	7.71	11.33	14.64	11.84	6.29	6.01	6.74	5.88
Cash per Share	3.78	4.95	6.13	2.72	6.98	8.64	8.90	0.99	1.00	2.56
Shareholders Equity per Share	64.92	61.38	56.63	51.12	51.86	50.81	42.44	38.73	36.17	33.29
Interest Debt per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share	64.92	61.38	56.63	51.12	51.86	50.81	42.44	38.73	36.17	33.29
Free Cash Flow	1,359.00	909.00	864.00	1,314.00	1,830.00	1,587.00	843.00	817.00	923.00	823.00
Working Capital	100.00	223.00	557.00	347.00	988.00	1,282.00	500.00	(95.00)	249.00	550.00
Capital Expenditures	(527.00)	(425.00)	(408.00)	(404.00)	(403.00)	(418.00)	(400.00)	(383.00)	(252.00)	(293.00)
Net Current Asset Value	(6,641.00)	(6,948.00)	(5,308.00)	(5,009.00)	(4,387.00)	(4,159.00)	(4,666.00)	(4,346.00)	(4,242.00)	(3,909.00)
EV/EBIT	15.75	16.65	15.69	15.22	10.40	9.55	14.53	13.70	14.76	12.78
Capex to Sales	0.05	0.04	0.04	0.04	0.04	0.04	0.05	0.05	0.03	0.04
Net Profit Margin	8.95%	8.77%	9.19%	9.53%	18.43%	15.10%	11.11%	9.77%	10.43%	8.90%
Price to Operating Income	12.38	12.44	12.50	12.65	9.08	8.10	11.62	10.29	11.63	10.14
Other line items
Depreciation/Fixed assets	0.26	0.23	0.24	0.25	0.24	0.22	0.23	0.24	0.24	0.24
Cash ROIC	(2.38%)	(5.74%)	(4.63%)	(0.47%)	4.63%	3.15%	(1.80%)	(0.95%)	0.34%	0.99%
Accounts Receivable Turnover	8.14	7.85	7.69	7.51	7.29	7.31	7.45	7.78	8.00	7.90
Accounts Payable Turnover	4.92	4.82	4.50	4.31	4.07	4.34	4.89	4.82	4.73	4.64
Inventory Turnover	39.10	35.07	32.46	32.25	30.53	33.55	45.38	50.78	53.32	55.61
Average Days of Payables	79.24	76.77	80.02	79.00	88.77	102.70	75.43	75.65	78.97	77.10
Days of Inventory on Hand	9.36	10.35	11.19	10.87	11.54	14.02	8.91	7.34	7.35	6.48
Average Receivables	1,356.00	1,257.00	1,202.50	1,316.50	1,479.00	1,291.50	1,037.50	968.00	925.00	913.50
Average Payables	1,497.00	1,376.50	1,377.50	1,498.00	1,616.50	1,337.00	1,031.00	1,021.00	998.00	994.50
Average Inventory	188.50	189.00	191.00	200.00	215.50	173.00	111.00	97.00	88.50	83.00
Average Assets	16,189.00	15,087.50	13,429.50	13,224.00	13,818.50	13,434.50	11,923.00	10,753.00	10,301.50	10,031.00
Average Common Equity	7,009.50	6,577.50	6,136.00	6,206.50	6,646.00	6,248.00	5,477.00	5,111.00	4,807.50	4,686.50

Show all line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Quest Diagnostics Incorporated DGX